Enliven Therapeutics, Inc.

Ownership Transactions Reported by 29 Insiders

Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
6200 Lookout Road, Boulder, CO

Insiders trading volume in the past year

Enliven Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Orbimed Advisors Llc Director, 10%+ Owner $170M -$22.9M -11.9% May 16, 2024
Rishi Gupta Director, 10%+ Owner $170M -$22.9M -11.9% May 16, 2024
David P. Bonita Director, 10%+ Owner $63.6M Jun 2, 2022
5AM Partners VI, LLC 10%+ Owner $57.2M -$19.8M -25.7% Feb 14, 2024
New Enterprise Associates 14, L.P. 10%+ Owner $39.5M Apr 5, 2022
Mark Chin Director $35.5M Jun 2, 2022
Ra Capital Management, L.P. Former 10% owner $32.1M Feb 23, 2023
Joseph P. Lyssikatos Chief Scientific Officer $30.5M -$4.72M -13.4% Oct 18, 2024
Braden Michael Leonard 10%+ Owner $30.2M Jan 3, 2023
Samuel Kintz PRESIDENT AND CEO, Director $30.1M -$4.64M -13.4% Oct 18, 2024
Barbara Dalton Director $23.6M Jun 2, 2022
Commodore Capital Lp 10%+ Owner $21.9M Feb 23, 2023
Carl Goldfischer Director $10.6M Jun 2, 2022
Anish Patel Chief Operating Officer $10.3M -$2.4M -18.9% Oct 18, 2024
Richard A. Heyman Director $4.53M -$615K -12% Oct 18, 2024
David Mott Director $3.47M Jun 2, 2022
Lori Anne Kunkel Director $891K Apr 8, 2024
Rahul Ballal Director $629K -$2.24M -78.1% Oct 8, 2024
Kenneth Attie Svp, Cmo $516K Jan 28, 2022
Michael Gray Cfo & Coo $418K Feb 22, 2023
Helen Louise Collins Chief Medical Officer $0 -$526K -100% Oct 18, 2024
Benjamin Hohl Chief Financial Officer $0 -$2.12M -100% Nov 27, 2024
Andrew John Phillips Director Feb 13, 2024
Jake Bauer Director Feb 13, 2024
Andrew J. Schwab Director, 10%+ Owner Feb 23, 2023
Mika K. Derynck Director Feb 13, 2024
Sara M. Nayeem Director Jun 29, 2021
Laura A. Williams Director Jun 2, 2022
Edward R. Conner Director Jun 2, 2022

Recent Insider Transactions by Companies or Individuals for Enliven Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.